US+1 646-781-8004
Europe+44-203-868-8738
APAC+91-744-778-0008
sales@meticulousresearch.com
HomePress-release
Redding, California - July 12, 2024

Biopharmaceutical Processing Equipment and Consumables Market to be Worth $83.39 Billion by 2031

Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D)- Global Forecast to 2031


Meticulous Research®– a leading global market research company, published a research report titled Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031.”

According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 9.5% to reach $83.39 billion by 2031. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and the growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.

Key Players

The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook

The global biopharmaceutical processing equipment and consumables market is segmented by Product Type (Filtration Systems, Chromatography Equipment and Consumables {Consumables & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research Bioproduction), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), & Academia and Research Institutes), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Based on product type, the global biopharmaceutical processing equipment and consumables market is segmented into filtration systems, chromatography equipment and consumables, bioreactors, cell culture products, mixers/mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, and other consumables and accessories. In 2024, the filtration systems segment is estimated to account for the largest share of 22.3% of the global biopharmaceutical processing equipment and consumables market. The large share of this segment is attributed to the recurring use of filtration at every step, the technological developments in filtration technologies, and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.

Based on application, the global biopharmaceutical processing equipment and consumables market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market. The large share of this segment is attributed to the growing number of biopharmaceuticals in clinical development and nearing patent expiry of biologics. Moreover, the large amounts of manufacturing of monoclonal antibodies required for the treatment of chronic diseases such as cancer, autoimmune diseases, and diabetes further contribute to the large share of the segment.

Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical and biopharmaceutical companies; contract development and manufacturing organizations (CDMO); and academic and research institutes. In 2024, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the global biopharmaceutical processing equipment and consumables market. The largest share of this segment is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in pharmaceutical and biopharmaceutical companies due to the high demand for biological products, favorable research initiatives resulting in the development of new biologics and biosimilars, and the high volumes of biopharmaceutical production globally.

Geographic Review

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Ireland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa. In 2024, Europe is estimated to account for the largest share of 33.2% of the biopharmaceutical processing equipment and consumables market. Further, in 2024, Germany is estimated to account for the largest share of the market in Europe. The large share of this market is primarily driven by the large volumes of pharmaceutical exports, government grants, and funding to biotech and biopharmaceutical companies, and biopharmaceutical companies expanding their capacities for biologics-based drugs and therapeutics to meet the increasing demand of the market.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=4200

Key Questions Answered in the Report:

  • Which are the high-growth market segments in terms of product type, application, end user, and regions/countries?
  • What was the historical market for biopharmaceutical processing equipment and consumables across the globe?
  • What are the market forecasts and estimates for the period 2024–2031?
  • What are the major drivers, restraints, challenges, opportunities, and trends in the global market of biopharmaceutical processing equipment and consumables?
  • Who are the major players in the global biopharmaceutical processing equipment and consumables market?
  • How is the competitive landscape, and who are the market leaders in the global biopharmaceutical processing equipment and consumables market?
  • What are the recent developments in the biopharmaceutical processing equipment and consumables market?
  • What are the different strategies adopted by the major players in the biopharmaceutical processing equipment and consumables market? 
  • What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Recommended Readings

Share this on:
Linkdin
Whatsapp
Print
Save PDF
  Download Free Sample Report
Table Of Content
Download Free Sample Report

Meticulous Research
US
+1 646-781-8004
Meticulous Research
Europe
+44-203-868-8738
Meticulous Research
APAC
+91-744-778-0008